Project HoloSurge
Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
Programme and Topic: HORIZON.2.1.5 - Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
Project duration: 2024 – 2027
UEG takes an active part in the project HoloSurge as a dissemination partner.
HoloSurge is a joint undertaking that brings European scientists and clinicians from high-tech companies, clinical centres, and research institutions in a consortium to deploy an innovative AI-based medical system that
- enables automatic fusion and segmentation of state-of-the-art imaging modalities for interactive 3D holographic visualization of patients’ organs;
- provides real-time surgical navigation, and
- allows real-time cell-level cancer diagnostics.
The solution will provide surgical teams with an unmatched holistic view of the patient’s anatomy and pathology in real-time at the point of care, before and during surgery. This innovation will be validated for cancer interventions while creating a trail of better-informed perioperative decision-making that can save countless lives.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No Project 101137233 — HoloSurge. Horizon Europe is the EU’s key funding programme for research and innovation, with a budget of €95.5 billion.
Read press release Access official factsheet Visit the HoloSurge website (coming soon)
Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.